Document Detail

Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons.
MedLine Citation:
PMID:  9733957     Owner:  NLM     Status:  MEDLINE    
Reactive oxygen species are thought to be involved in the death of dopaminergic neurons in Parkinson's disease as well as in transplanted embryonic dopaminergic neurons. The spin-trap agent alpha-phenyl-N-tert-butyl nitrone (PBN) reacts directly with radical species and may thereby prevent them from damaging important cellular molecules such as membrane lipids. We found that PBN does not increase the survival of cultured embryonic dopaminergic neurons subjected to serum deprivation, whereas the antioxidant and lipid peroxidation inhibitor lazaroid U-83836E does. Moreover, PBN does not increase the survival of grafted embryonic dopaminergic neurons or graft efficacy (monitored as changes in drug-induced motor asymmetry in hemiparkinsonian rats) when the spin-trap agent is given intraperitoneally to the graft recipient or is added to the solutions used when preparing tissue for transplantation. Another spin-trap agent, alpha-(4-pyridyl-1-oxide)-N-tert-butyl nitrone (POBN) also failed to protect neurons when given to graft recipients in the same experimental paradigm. Finally, we found that adult nigral neurons subjected to a progressive retrograde 6-OHDA lesion are not protected by systemic treatment with PBN. Even though reduction of oxidative stress by overexpression of superoxide dismutase or addition of lazaroids have previously been shown to enhance the survival of cultured and grafted dopaminergic neurons, spin-trap agents PBN and POBN do not provide protection in these experimental paradigms. This may be due to antioxidants and spin-trap agents interfering in different steps of free radical-induced cell damage.
J Karlsson; M Emgârd; C Rosenblad; P Brundin
Related Documents :
1258607 - Neuropathological considerations in cerebro-hepato-renal syndrome (zellweger's syndrome).
9886827 - Effects of suprachiasmatic transplants on circadian rhythms of neuroendocrine function ...
8859897 - Regional study of spinal alpha 2-adrenoceptor densities after intraspinal noradrenergic...
9506557 - In vivo pet imaging in rat of dopamine terminals reveals functional neural transplants.
7742747 - Detection of donor lymphocytes in the cerebrospinal fluid of a patient with metachromat...
19180887 - Two-year observation of a randomized trial on tacrolimus-based therapy with withdrawal ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Brain research     Volume:  805     ISSN:  0006-8993     ISO Abbreviation:  Brain Res.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-25     Completed Date:  1998-11-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  155-68     Citation Subset:  IM    
Copyright Information:
Copyright 1998 Elsevier Science B.V.
Wallenberg Neuroscience Center, Section for Neuronal Survival, Department of Physiology and Neuroscience, Lund University, Sölvegatan 17, S-223 62, Lund, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aging / physiology
Cell Survival / drug effects
Cell Transplantation
Cells, Cultured
Cyclic N-Oxides
Dopamine / metabolism*
Fetal Tissue Transplantation
Graft Survival / drug effects
Mesencephalon / cytology,  embryology
Neurons / drug effects*,  pathology,  physiology*
Nitrogen Oxides / pharmacology*
Parkinson Disease, Secondary / surgery
Rats, Sprague-Dawley
Spin Labels
Substantia Nigra / pathology
Reg. No./Substance:
0/Cyclic N-Oxides; 0/Nitrogen Oxides; 0/Spin Labels; 3376-24-7/phenyl-N-tert-butylnitrone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aggregation of dimyristoylphosphatidylglycerol liposomes by human plasma low density lipoprotein.
Next Document:  Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest de...